Professional corporate website development
in Cambridge

Cambridge corporate clients — Moderna substantial Kendall Square operations, Biogen global headquarters, Akamai Technologies global headquarters, HubSpot global headquarters, Novartis Institutes for BioMedical Research global research operations, Alnylam Pharmaceuticals, Editas Medicine, Beam Therapeutics, bluebird bio, Microsoft New England R&D Center, the Broad Institute, the Whitehead Institute — require websites with engineering-grade architectural discipline matching their global operational standards. Generic Boston agencies often deliver corporate sites that fail Cambridge technical scrutiny.

Effective corporate sites include investor relations infrastructure (substantial Cambridge publicly traded biotech and tech companies — Moderna, Biogen, Akamai, HubSpot, Alnylam, Editas, Beam, bluebird bio all publicly traded requiring SEC-compliant investor relations infrastructure), comprehensive product and capability documentation, certification and compliance documentation (FDA for biotech, SOC 2, ISO 27001 for cybersecurity context like Akamai-area), supplier and partner portal access, careers infrastructure (substantial for Cambridge biotech and tech competing globally for scientific and engineering talent), news and press systems, and multilingual support given Cambridge's substantially international audience.

Corporate website projects for Cambridge enterprises typically require 14-26 weeks reflecting comprehensive content development, multiple stakeholder approvals across corporate governance, integration with existing enterprise systems, regulatory review for biotech contexts, and security/compliance review. Mid-size operations move faster (10-16 weeks). Cambridge startup ecosystem businesses with focused scope can complete corporate sites in 6-12 weeks.

SEC compliance is fundamental to publicly traded biotech corporate site architecture. We implement investor relations infrastructure supporting SEC disclosure requirements, Regulation FD compliance throughout disclosure-related content, SOX documentation requirements, financial reporting integration, press release distribution supporting investor disclosure, and proper audit trails. For Cambridge's substantial publicly traded biotech and tech ecosystem (Moderna, Biogen, Akamai, HubSpot, Alnylam, Editas, Beam, bluebird bio), SEC compliance is regulatory requirement built into corporate site foundation.

Yes — corporate site integration is core to our enterprise practice. We integrate with SAP, Oracle, Microsoft Dynamics, Salesforce, ServiceNow, Workday, and the enterprise platforms Cambridge corporate operations standardize on. For Moderna-scale or Biogen-scale biotech, additional integration with FDA-compliant clinical trial management systems, pharmaceutical research databases, and regulatory submission systems. For Akamai-scale tech, integration with global CDN and cybersecurity infrastructure. For HubSpot-area context, marketing technology integration.

Corporate site governance includes documented information architecture, content publishing workflows with appropriate approval chains, role-based access control supporting corporate hierarchies, change tracking and audit trails (essential for publicly traded companies and FDA-regulated biotech), brand standards enforcement, and SLA-backed maintenance commitments. For Cambridge's substantial publicly traded biotech and tech operations, governance accommodates SOX compliance documentation requirements. For biotech, FDA documentation requirements throughout.

We adapt to corporate communication patterns common in Cambridge — formal kickoff with comprehensive stakeholder mapping, structured weekly status reports, milestone-based reviews with appropriate executive participation, formal change request processes, and respectful long-term relationship development. For Moderna-scale or Biogen-scale biotech, additional FDA review processes and regulatory governance shape communication. For Akamai-scale tech, technical sophistication and global operational scale shape communication. For Harvard and MIT institutional clients, academic governance patterns.

Corporate site post-launch support includes comprehensive maintenance covering security patches, performance monitoring, content management training and support, technical support for editorial teams, ongoing development capacity for site evolution, and SLA-backed response commitments for issue resolution. For Cambridge's larger corporate clients (Moderna-scale, Biogen-scale, Akamai-scale, HubSpot-scale, Novartis NIBR-area), enterprise-grade support tier with appropriate response time commitments.